Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousDuring prosecution, claims are indefinite when amenable to multiple plausible constructions
By Dennis Crouch, Esq.
Ex parte Miyazaki (BPAI Precedential 2008)
In a rare precedential opinion, the Board of Patent Appeals and Interferences (BPAI) has re-defined the standard for a §112 indefiniteness rejection during patent prosecution. The BPAI's definition for pre-issuance indefiniteness focuses on 'plausible' indefiniteness and varies dramatically from the Federal Circuit's standard of 'insolubly ambiguous.' The BPAI argues that a lower threshold of ambiguity is justified pre-issuance because it gives the PTO power to ensure that claims are "precise, clear, correct, and unambiguous."
As such, we employ a lower threshold of ambiguity when reviewing a pending claim for indefiniteness than those used by post-issuance reviewing courts. In particular, rather than requiring that the claims are insolubly ambiguous, we hold that if a claim is amenable to two or more plausible claim constructions, the USPTO is justified in requiring the applicant to more precisely define the metes and bounds of the claimed invention by holding the claim unpatentable under 35 U.S.C. § 112, second paragraph, as indefinite. |
The expanded indefiniteness examination runs parallel to the PTO's approach of broadly construing claims during prosecution. Both tactics are intended to better ensure that issued patents can be counted-on as being valid patents.
The Federal Circuit's insolubly ambiguous standard is premised on the strong presumption of validity associated with an issued patent. The BPAI grounds its lower threshold in the notion that patent applications have no presumption of validity.
Read the BPAI Miyazaki Opinion: http://www.uspto.gov/web/offices/dcom/bpai/prec/fd073300.pdf
Full post as published by Patently Obvious on December 08, 2008 (boomark / email).
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
False Claims
Attorney Robert Arledge ordered to pay $5.8 million after making false Fen Phen settlement claims.
LINA - Cigna Life Insurance Company of North America Disability Claims
LINA Insurance alleging violations of disability insurance claims.
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Archdiocese of Denver
Settles 5.5 million in claims
BP
Settles More Claims From Texas Refinery Explosion
Warranty Parts Claims
Delphi Corp. must pay GM $200 million.

BPAI's Miyazaki: two or more plausible constructions, out under 112
Judgment for Patent defendant following claims construction ruling; Claims Indefinite
CAFC Comments on use of a and the in Claims
Federal Circuit reaffirms anticipatory reference must have all elements as arranged in the claim
Heuft: CAFC rules on infectious prosecution disclaimers








